1. Low-Dose Rituximab for Active Moderate to Severe Graves' Orbitopathy Resistant to Conventional Treatment. (4th July 2019) Authors: Du Pasquier-Fediaevsky, Laurence; Andrei, Stefan; Berche, Michel; Leenhardt, Laurence; Héron, Emmanuel; Rivière, Sébastien Journal: Ocular immunology and inflammation Issue: Volume 27:Number 5(2019) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗